Prussian blue analog with separated active sites to catalyze water driven enhanced catalytic treatments.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37543632.
- Also identified by DOI 10.1038/s41467-023-40470-z and PMC identifier 10404294.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Chemodynamic therapy (CDT) uses the Fenton or Fenton-like reaction to yield toxic ‧OH following H<sub>2</sub>O<sub>2</sub> → ‧OH for tumoral therapy. Unfortunately, H<sub>2</sub>O<sub>2</sub> is often taken from the limited endogenous supply of H<sub>2</sub>O<sub>2</sub> in cancer cells. A water oxidation CoFe Prussian blue (CFPB) nanoframes is presented to provide sustained, external energy-free self-supply of ‧OH from H<sub>2</sub>O to process CDT and/or photothermal therapy (PTT). Unexpectedly, the as-prepared CFPB nanocubes with no near-infrared (NIR) absorption is transformed into CFPB nanoframes with NIR absorption due to the increased Fe<sup>3+</sup>-N ≡ C-Fe<sup>2+</sup> composition through the proposed proton-induced metal replacement reactions. Surprisingly, both the CFPB nanocubes and nanoframes provide for the self-supply of O<sub>2</sub>, H<sub>2</sub>O<sub>2,</sub> and ‧OH from H<sub>2</sub>O, with the nanoframe outperforming in the production of ‧OH. Simulation analysis indicates separated active sites in catalyzation of water oxidation, oxygen reduction, and Fenton-like reactions from CFPB. The liposome-covered CFPB nanoframes prepared for controllable water-driven CDT for male tumoral mice treatments.
Medical subject headings
- Neoplasms
- Nanoparticles